Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2009-012654-20-IT
EUCTR2009-012654-20-IT
Active, not recruiting
Not Applicable

sistemic thrombolysis with Alteplase between 3-4.5 hours in acute ischaemic stroke. Evaluation of clinical efficacy - ND

POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 sitesMay 26, 2009
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsIschaemic strokeMedDRA version: 9.1Level: PTClassification code 10014498MedDRA version: 9.1Level: PTClassification code 10043647
DrugsACTILYSE*IV FL 50MG+FL 50ML

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ischaemic stroke
Sponsor
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
Status
Active, not recruiting
Last Updated
12 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 26, 2009
End Date
TBD
Last Updated
12 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI

Eligibility Criteria

Inclusion Criteria

  • •\- ischaemic stroke between 3\-4\.5 hours from onset
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •\- contraindication of thrombolysis

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
IV THROMBOLYSIS(rt PA-Alteplase) AS TREATMEANT IN SEVERE COVID ARDSHealth Condition 1: J80- Acute respiratory distress syndromeHealth Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere
CTRI/2021/08/035445COLUMBIA ASIA REFERRAL HOSITA
Withdrawn
Phase 3
Efficacy and Safety of Half Dose Alteplase Added to Heparine, in Patients With Moderate Pulmonary EmbolismPulmonary Embolism
NCT02604238Azienda U.S.L. 1 di Massa e Carrara
Completed
Not Applicable
Study of need for thrombolytic therapy and incidence of bacteremia using taurolidine-citrate-heparin, taurololidine-citrate and heparin catheter locks in patients treated with haemodialysis
ISRCTN07668752ancashire Teaching Hospitals NHS trust (UK)106
Not yet recruiting
Phase 4
Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits
NCT06115070Second Affiliated Hospital, School of Medicine, Zhejiang University390
Active, not recruiting
Phase 1
Comparing three different treatment options for acute clots in the pulmonary vesselsAcute Pulmonary Embolism, intermediate high risk (visible impact on right ventricular structure and function, and biochemical markers og myocardial damage according to the European Society of Cardiology Guidelines)MedDRA version: 21.0Level: PTClassification code 10037377Term: Pulmonary embolismSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2017-005075-91-DKCopenhagen University Hospital Rigshospitalet210